Harbor Capital Advisors’s Enfusion, Inc. ENFN Stock Holding History

Harbor Capital Advisors’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,201	Closed	-$114K	–	1439
2025 Q1	$114K	Buy	10,201 +2,366	+30%	+$26.2K	0.01%	648
2024 Q4	$81K	Sell	7,835 -4,052	-34%	-$39.2K	﹤0.01%	711
2024 Q3	$113K	Buy	11,887 +1,315	+12%	+$11.3K	﹤0.01%	714
2024 Q2	$90K	Buy	10,572 +828	+8%	+$7.58K	0.01%	705
2024 Q1	$90K	Buy	+9,744	New	+$85.7K	0.01%	712

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbor Capital Advisors's ENFN Position: Q2 2025 in Review

Harbor Capital Advisors sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 10,201 shares — an estimated $114K sold.

Harbor Capital Advisors first reported a position in ENFN in Q1 2024 and held it in 5 quarters. The position peaked at $114K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Harbor Capital Advisors reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Harbor Capital Advisors sold 10,201 Enfusion, Inc. shares in Q2 2025, an estimated $114K.
Harbor Capital Advisors first reported a position in Enfusion, Inc. in Q1 2024 and held it in 5 quarters.
Harbor Capital Advisors's Enfusion, Inc. position peaked at $114K in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Harbor Capital Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.